Institut Catala d'Oncologia Hospitalet, Avenida Gran Via 199-203

L'Hospitalet de Llobregat 08908

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC) — Completed